2010
DOI: 10.1007/s13206-010-4202-0
|View full text |Cite
|
Sign up to set email alerts
|

TOXPO: TOXicogenomics knowledgebase for inferring toxicity based on POlymorphism

Abstract: Recently, many state-of-the-art omics technologies are being applied to systems toxicology research because evaluation of toxicity in pre-clinical trials is a big issue in the pharmaceutical industry. Now, genetic polymorphisms are also considered in systems toxicology because polymorphism information can be used to explain individual-specific toxicity and/ or side effects. However, in spite of its importance, no well-organized database for individual toxicity has been reported to date. To address this issue, … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2011
2011
2019
2019

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 18 publications
0
1
0
Order By: Relevance
“…For example, many variants have been found to exhibit interactions with environments of one sort or another in the context of disease susceptibility [53]. However, more specific interactions involving drugs or chemicals have received a great deal of recent attention and have led to databases cataloging evidence for such interactions, such as the ToxPO database [54] and, importantly, the Pharmacogenetics Knowledge Base or ‘PharmGKB’ [55]. Many studies and databases providing context-specific functional annotations of genetic variants are not necessarily population-based, but may leverage specific laboratory or model-organism based functional assays [56].…”
Section: Types Of Annotationmentioning
confidence: 99%
“…For example, many variants have been found to exhibit interactions with environments of one sort or another in the context of disease susceptibility [53]. However, more specific interactions involving drugs or chemicals have received a great deal of recent attention and have led to databases cataloging evidence for such interactions, such as the ToxPO database [54] and, importantly, the Pharmacogenetics Knowledge Base or ‘PharmGKB’ [55]. Many studies and databases providing context-specific functional annotations of genetic variants are not necessarily population-based, but may leverage specific laboratory or model-organism based functional assays [56].…”
Section: Types Of Annotationmentioning
confidence: 99%